MedTrace Logo

Cracking the Egg Potential: Improving Young Child Nutrition in Ecuador

NCT02446873 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2018-06-19

No results posted yet for this study

Summary

The proposed study will fill an important gap in the literature by examining, through a randomized controlled trial, the effect of egg consumption on biochemical markers of choline, vitamin B-12, lipids, and amino acids in young children in a poor rural area of Ecuador. Children from Cotopaxi Province, Ecuador (n=180) will be randomized into one of two groups: 1) intervention, receiving one egg per day for six months; or 2) control. Baseline and endline data on socio-economic factors, and child diet, morbidities, and anthropometry will be collected. Blood will also be drawn from the children at these time points for nutrient biomarker analyses. Through qualitative research the proposed study will provide insight into the attitudes, beliefs, and use of eggs by mothers and other caregivers during the complementary feeding period. The University of San Francisco in Quito (USFQ) will be the lead field coordinator of the research working in partnership with Washington University in St. Louis, Pan-American Health Organization (PAHO) and University of California, Davis.

Conditions

  • Choline Deficiency
  • Vitamin B-12 Deficiency
  • Lipids Deficiency
  • Amino Acids Deficiency

Interventions

OTHER

Egg supplementation

A weekly supply of eggs will be given to the mother in the egg supplementation group with instructions to give the child one egg per day.

Sponsors & Collaborators

  • Universidad San Francisco de Quito

    collaborator OTHER

  • Pan American Health Organization

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Lora Iannotti, PhD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
9 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Ecuador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02446873 on ClinicalTrials.gov